THURSDAY, Sept. 12, 2024 -- Liraglutide plus lifestyle intervention is efficacious for children aged 6 to
Vous n'êtes pas connecté
TUESDAY, Sept. 10, 2024 -- For patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, according to a study published online Sept. 9 in the New England Journal of Medicine to coincide...
THURSDAY, Sept. 12, 2024 -- Liraglutide plus lifestyle intervention is efficacious for children aged 6 to
TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...
TUESDAY, Sept. 10, 2024 -- Having asthma appears linked to raised odds for miscarriage and troubles with fertility among women, new Danish research...
TUESDAY, Sept. 10, 2024 -- For adults aged 30 to 49 years, there has been a decline in melanoma incidence and mortality, according to a study...
TUESDAY, Sept. 17, 2024 -- Cardiovascular devices with Class I recalls appear to be rarely subjected to premarket or postmarket testing, according to...
WEDNESDAY, Sept. 4, 2024 -- Efforts to rule out bladder tumors and tuberculosis are still essential in the follow-up of patients with suspected...
TUESDAY, Sept. 17, 2024 -- The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with...
TUESDAY, Sept. 17, 2024 -- A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with...
TUESDAY, Sept. 10, 2024 -- Across hospital types, there is a comparably detrimental relationship between COVID-19 caseload and patient survival,...
THURSDAY, Sept. 5, 2024 -- For older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to a...